A DNA-Modularized STING Agonist with Macrophage-Selectivity and Programmability for Enhanced Anti-Tumor Immunotherapy.
Chen Y, Li R, Duan Q, Wu L, Li X, Luo A, Zhang Y, Zhao N, Cui K, Wu W, Liu T, Wan JB, Deng L, Li G, Hou L, Tan W, Xiao Z.
Chen Y, et al. Among authors: li r.
Adv Sci (Weinh). 2024 Jun 19:e2400149. doi: 10.1002/advs.202400149. Online ahead of print.
Adv Sci (Weinh). 2024.
PMID: 38898748